4basebio PLC (88Q.DE)

EUR 14.6

(0.0%)

Long Term Debt Summary of 4basebio PLC

  • 4basebio PLC's latest annual long term debt in 2023 was 10.06 Million GBP , up 242.93% from previous year.
  • 4basebio PLC's latest quarterly long term debt in 2023 FY was 10.06 Million GBP , up 242.93% from previous quarter.
  • 4basebio PLC reported annual long term debt of 2.93 Million GBP in 2022, up 121.34% from previous year.
  • 4basebio PLC reported annual long term debt of 1.32 Million GBP in 2021, up 1.92% from previous year.
  • 4basebio PLC reported quarterly long term debt of 10.06 Million GBP for 2023 FY, up 242.93% from previous quarter.
  • 4basebio PLC reported quarterly long term debt of - GBP for 2023 Q2, down -100.0% from previous quarter.

Annual Long Term Debt Chart of 4basebio PLC (2023 - 2019)

Historical Annual Long Term Debt of 4basebio PLC (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 10.06 Million GBP 242.93%
2022 2.93 Million GBP 121.34%
2021 1.32 Million GBP 1.92%
2020 1.3 Million GBP -39.26%
2019 2.14 Million GBP 0.0%

Peer Long Term Debt Comparison of 4basebio PLC

Name Long Term Debt Long Term Debt Difference
BioNTech SE 191 Million EUR 94.73%
CureVac N.V. 36.81 Million EUR 72.664%
Biotest Aktiengesellschaft 377.3 Million EUR 97.332%
Biotest Aktiengesellschaft 377.3 Million EUR 97.332%
BRAIN Biotech AG 25.19 Million EUR 60.048%
Formycon AG 7.81 Million EUR -28.791%
Heidelberg Pharma AG 70.4 Thousand EUR -14195.454%
Medigene AG 2.03 Million EUR -394.352%